Skip to content
BIO-Europe Spring 2024

Event Information:


From: 18 March, 2024
To: 20 March, 2024


Barcelona, Spain

Related Models

Immuno-Oncology, Humanized Mouse Models

Unlock the Promises of Humanized mouse models with TransCure BioServices at BIO-Europe Spring 2024 in Barcelona!

TransCure BioServices is thrilled to extend an invitation to join us at the premier springtime partnering event for the global biopharma community, BIO-Europe Spring 2024. Set in the vibrant city of Barcelona from March 18–20, 2024, this event stands as a cornerstone for elevating life science partnerships and connecting industry professionals across the globe.

BIO-Europe Spring 2024 is not just a conference; it’s an opportunity to enhance your knowledge and stay informed about the latest trends in key therapeutic areas, including oncology, cell and gene therapy, neuroscience, infectious diseases, inflammation and rare disease. By attending, you’ll experience dynamic discussions led by pharmaceutical and biotech thought leaders, shedding light on the current financial, deal-making, and partnering landscape within the life science ecosystem. This event promises to delve into the critical focus on sustainability while introducing you to the leaders of tomorrow, driving innovation in our industry.

Moreover, the summit offers a unique platform to explore life science ecosystems on both local and global scales, revealing the current state of the manufacturing industry through engaging case studies. Learn about the successes and pitfalls of regional developments and discover novel solutions from companies addressing unmet needs.

At TransCure BioServices, we are excited to showcase our humanized mouse models, which are at the forefront of advancing preclinical research. Our models play a pivotal role in revolutionizing cancer treatment, combating inflammatory diseases, and developing HIV treatments. Dr. Sébastien TABRUYN, our CEO, will be available to discuss our technology, study designs and demonstrate how our innovative solutions can meet the industry’s evolving needs.

We look forward to meeting you in Barcelona to join forces and shape the future of preclinical research together.

Let’s connect, learn, and innovate at the heart of the global biopharma community. See you in Barcelona!

Sebastien Tabruyn, PhDAttending in person for TransCure BioServices:

Sebastien Tabruyn, PhD, General Director

Sebastien Tabruyn holds a PhD in Molecular Biology from the University of Liege (Belgium). With over 20 years of experience as a Project Leader in worldwide academic research institutes, including UCSF (California, USA), the Centre for Cancer Biology (Adelaide, Australia), and the University of Maastricht (Netherlands), Sebastien joined TransCure bioServices in 2013 to develop the first immune-oncology humanized mouse models. Before taking on the role of CEO, Sebastien served as the company’s Chief Scientific Officer for six years, where he was instrumental in driving scientific excellence and innovation. Sebastien Tabruyn has published more than 35 peer-reviewed publications, primarily focusing on oncology, inflammation, immunity, and angiogenesis. As CEO, Sebastien commits his leadership and vision to the expansion of TransCure bioServices through the successful delivery of its client needs.

This event has concluded